Soleno Therapeutics Inc
NASDAQ:SLNO
Income Statement
Earnings Waterfall
Soleno Therapeutics Inc
Income Statement
Soleno Therapeutics Inc
| Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
3
|
2
|
2
|
2
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
4
|
0
|
|
| Revenue |
3
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+500%
|
0
+208%
|
1
+65%
|
1
-3%
|
0
-17%
|
0
-51%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
33
N/A
|
99
+202%
|
190
+93%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+238%
|
0
-7%
|
0
-8%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
32
N/A
|
97
+203%
|
188
+94%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(4)
|
(3)
|
(4)
|
(4)
|
(5)
|
(7)
|
(9)
|
(11)
|
(12)
|
(13)
|
(12)
|
(10)
|
(8)
|
(7)
|
(8)
|
(9)
|
(12)
|
(14)
|
(15)
|
(16)
|
(14)
|
(14)
|
(16)
|
(18)
|
(23)
|
(28)
|
(33)
|
(35)
|
(36)
|
(36)
|
(36)
|
(37)
|
(32)
|
(28)
|
(24)
|
(22)
|
(24)
|
(27)
|
(29)
|
(33)
|
(41)
|
(56)
|
(72)
|
(142)
|
(188)
|
(210)
|
(224)
|
(186)
|
(178)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(7)
|
(8)
|
(8)
|
(8)
|
(7)
|
(6)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(12)
|
(13)
|
(19)
|
(27)
|
(73)
|
(106)
|
(127)
|
(144)
|
(129)
|
(132)
|
|
| Research & Development |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(9)
|
(11)
|
(13)
|
(16)
|
(20)
|
(23)
|
(23)
|
(23)
|
(24)
|
(23)
|
(23)
|
(21)
|
(18)
|
(16)
|
(15)
|
(15)
|
(17)
|
(18)
|
(20)
|
(25)
|
(34)
|
(42)
|
(66)
|
(79)
|
(77)
|
(74)
|
(53)
|
(41)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
(3)
|
(3)
|
(1)
|
(0)
|
1
|
2
|
(0)
|
(1)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
1
|
1
|
3
|
3
|
1
|
(0)
|
(0)
|
(1)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(6)
|
(5)
|
(5)
|
(6)
|
|
| Operating Income |
(1)
N/A
|
(3)
-301%
|
(4)
-4%
|
(4)
-9%
|
(5)
-33%
|
(7)
-34%
|
(9)
-25%
|
(11)
-22%
|
(12)
-16%
|
(13)
-5%
|
(11)
+12%
|
(10)
+11%
|
(8)
+17%
|
(7)
+20%
|
(8)
-22%
|
(9)
-8%
|
(12)
-38%
|
(14)
-17%
|
(15)
-3%
|
(16)
-8%
|
(14)
+10%
|
(14)
+3%
|
(16)
-16%
|
(18)
-14%
|
(23)
-29%
|
(28)
-18%
|
(33)
-20%
|
(35)
-5%
|
(36)
-3%
|
(36)
+0%
|
(36)
+0%
|
(37)
-1%
|
(32)
+14%
|
(28)
+11%
|
(24)
+15%
|
(22)
+9%
|
(24)
-12%
|
(27)
-11%
|
(29)
-7%
|
(33)
-14%
|
(41)
-25%
|
(56)
-35%
|
(72)
-29%
|
(142)
-97%
|
(188)
-32%
|
(210)
-12%
|
(192)
+9%
|
(89)
+53%
|
9
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(3)
|
(2)
|
(2)
|
(2)
|
(4)
|
(4)
|
(3)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
7
|
11
|
12
|
12
|
11
|
11
|
11
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(1)
|
(1)
|
(5)
|
(14)
|
(8)
|
(8)
|
(4)
|
7
|
2
|
2
|
2
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(4)
|
(2)
|
0
|
(2)
|
(3)
|
3
|
(7)
|
(2)
|
7
|
(1)
|
12
|
8
|
5
|
5
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(6)
-50%
|
(6)
-11%
|
(7)
-13%
|
(14)
-99%
|
(25)
-78%
|
(20)
+19%
|
(21)
-4%
|
(16)
+24%
|
(6)
+61%
|
(10)
-55%
|
(8)
+16%
|
(7)
+17%
|
(7)
-1%
|
(8)
-22%
|
(9)
-9%
|
(13)
-49%
|
(15)
-9%
|
(18)
-24%
|
(18)
+1%
|
(12)
+35%
|
(16)
-32%
|
(19)
-22%
|
(16)
+17%
|
(31)
-95%
|
(30)
+4%
|
(27)
+9%
|
(36)
-35%
|
(25)
+32%
|
(28)
-13%
|
(31)
-13%
|
(31)
+1%
|
(31)
+0%
|
(28)
+10%
|
(23)
+15%
|
(21)
+9%
|
(24)
-12%
|
(27)
-11%
|
(28)
-7%
|
(33)
-17%
|
(39)
-17%
|
(52)
-32%
|
(65)
-26%
|
(131)
-101%
|
(176)
-34%
|
(198)
-13%
|
(181)
+9%
|
(78)
+57%
|
21
N/A
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(6)
|
(6)
|
(7)
|
(14)
|
(25)
|
(20)
|
(21)
|
(16)
|
(6)
|
(10)
|
(8)
|
(7)
|
(7)
|
(8)
|
(9)
|
(1)
|
(2)
|
(6)
|
(6)
|
(12)
|
(16)
|
(19)
|
(16)
|
(31)
|
(30)
|
(27)
|
(36)
|
(25)
|
(28)
|
(31)
|
(31)
|
(31)
|
(28)
|
(23)
|
(21)
|
(24)
|
(27)
|
(28)
|
(33)
|
(39)
|
(52)
|
(65)
|
(131)
|
(176)
|
(198)
|
(181)
|
(78)
|
21
|
|
| Net Income (Common) |
(4)
N/A
|
(6)
-50%
|
(6)
-11%
|
(7)
-13%
|
(14)
-99%
|
(25)
-78%
|
(20)
+19%
|
(21)
-4%
|
(16)
+24%
|
(7)
+53%
|
(13)
-72%
|
(12)
+4%
|
(16)
-28%
|
(15)
+2%
|
(16)
-3%
|
(17)
-7%
|
(15)
+9%
|
(16)
-6%
|
(19)
-19%
|
(18)
+5%
|
(13)
+27%
|
(17)
-24%
|
(20)
-18%
|
(16)
+19%
|
(31)
-94%
|
(30)
+4%
|
(27)
+9%
|
(36)
-35%
|
(25)
+32%
|
(28)
-13%
|
(31)
-13%
|
(31)
+1%
|
(31)
+0%
|
(28)
+10%
|
(23)
+15%
|
(21)
+9%
|
(24)
-12%
|
(27)
-11%
|
(28)
-7%
|
(33)
-17%
|
(39)
-17%
|
(52)
-32%
|
(65)
-26%
|
(131)
-101%
|
(176)
-34%
|
(198)
-13%
|
(181)
+9%
|
(78)
+57%
|
20
N/A
|
|
| EPS (Diluted) |
-41.22
N/A
|
-61.66
-50%
|
-68.66
-11%
|
-77.55
-13%
|
-154.11
-99%
|
-274.33
-78%
|
-200.2
+27%
|
-160.92
+20%
|
-122.38
+24%
|
-37.2
+70%
|
-61.09
-64%
|
-58.52
+4%
|
-74.85
-28%
|
-45.32
+39%
|
-25.19
+44%
|
-26.42
-5%
|
-25.65
+3%
|
-12.53
+51%
|
-14.25
-14%
|
-12.82
+10%
|
-9.52
+26%
|
-7.81
+18%
|
-9.2
-18%
|
-7.49
+19%
|
-13.49
-80%
|
-9.93
+26%
|
-8.75
+12%
|
-6.85
+22%
|
-5.9
+14%
|
-5.22
+12%
|
-5.91
-13%
|
-5.83
+1%
|
-5.81
+0%
|
-5.2
+10%
|
-2.92
+44%
|
-2.64
+10%
|
-2.87
-9%
|
-2.82
+2%
|
-2.73
+3%
|
-2.9
-6%
|
-2.36
+19%
|
-1.43
+39%
|
-1.67
-17%
|
-3.12
-87%
|
-4.38
-40%
|
-4.29
+2%
|
-3.58
+17%
|
-1.42
+60%
|
0.39
N/A
|
|